Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
D000107:Acetylation; D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000097:blood; D003092:Colitis / Q000188:drug therapy; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012463:Saliva / Q000032:analysis; D013424:Sulfanilamides / Q000097:blood*; D013427:Sulfapyridine / Q000031:analogs & derivatives / Q000097:blood* / Q000652:urine; D012460:Sulfasalazine / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D013424:Sulfanilamides; C005377:N-acetylsulfapyridine; D012460:Sulfasalazine; D013427:Sulfapyridine